| Filed | As-Of/On | Form | Fullname | Symbol | Country | Industry | Shares | Activity | Shares Change | Shares Pct. Change | Hypothetical Old Value | Hypothetical New Value | Hypothetical Value Chg. | Hypothetical Return | Hypothetical Results |
Director |
Other |
Ten Pct |
Officer |
Officer Title |
News Article |
History |
|---|
| 2009-11-02 | 2009-08-31 | N-CSRS | Eisai Co Ltd | ESALY.OB | JP | Medical-Drugs | 0 | Sold All | -500 | -100 % | - | - | - | - % | | | | | | | News Article | History of Fidelity Select Portfolios - Pharmaceuticals Portfolio Ownership Of Eisai Co Ltd |
| 2009-11-02 | 2009-08-31 | N-CSRS | Bayer Ag | BAYZF.OB | US | Chemicals-Diversified | 4,300 | Sold Some | -4,000 | -48.19 % | - | - | - | - % | | | | | | | News Article | History of Fidelity Select Portfolios - Pharmaceuticals Portfolio Ownership Of Bayer Ag |
| 2009-11-02 | 2009-08-31 | N-CSRS | Reckitt Benckiser Group Plc | RBGPF.OB | GB | Soap And Cleaning Prepar | 100 | New Holding | 100 | 100 % | - | - | - | - % | | | | | | | News Article | History of Fidelity Select Portfolios - Pharmaceuticals Portfolio Ownership Of Reckitt Benckiser Group Plc |
| 2009-11-02 | 2009-08-31 | N-CSRS | Merck Kgaa | MKGAF.PK | DE | Medical-Drugs | 900 | Sold Some | -11,100 | -92.50 % | - | - | - | - % | | | | | | | News Article | History of Fidelity Select Portfolios - Pharmaceuticals Portfolio Ownership Of Merck Kgaa |
| 2009-11-02 | 2009-08-31 | N-CSRS | Sawai Pharmaceutical Co Ltd | 4555.T | JP | Medical-Generic Drugs | 3,000 | New Holding | 3,000 | 100 % | - | - | - | - % | | | | | | | News Article | History of Fidelity Select Portfolios - Pharmaceuticals Portfolio Ownership Of Sawai Pharmaceutical Co Ltd |
| 2009-11-02 | 2009-08-31 | N-CSRS | Akorn Inc | AKRX | US | Medical-Drugs | 26,100 | Added More | 10,000 | 62.11 % | $39,150 | $42,021 | $2,871 | 7.33 % | $1,100 | | | | | | News Article | History of Fidelity Select Portfolios - Pharmaceuticals Portfolio Ownership Of Akorn Inc |
| 2009-11-02 | 2009-08-31 | N-CSRS | Amag Pharmaceuticals Inc | AMAG | BE | Medical-Biomedical/Gene | 1,200 | Sold Some | -2,800 | -70.00 % | $47,784 | $47,700 | $-84 | -0.17 % | $196 | | | | | | News Article | History of Fidelity Select Portfolios - Pharmaceuticals Portfolio Ownership Of Amag Pharmaceuticals Inc |
| 2009-11-02 | 2009-08-31 | N-CSRS | Hikma Pharmaceuticals Plc | HKMPF.PK | GB | Medical-Drugs | 18,000 | Added More | 8,000 | 80.00 % | - | - | - | - % | | | | | | | News Article | History of Fidelity Select Portfolios - Pharmaceuticals Portfolio Ownership Of Hikma Pharmaceuticals Plc |
| 2009-11-02 | 2009-08-31 | N-CSRS | Illumina Inc | ILMN | US | Medical-Biomedical/Gene | 24,700 | No Change | 0 | 0 % | $797,316 | $662,207 | $-135,109 | -16.94 % | $0 | | | | | | News Article | History of Fidelity Select Portfolios - Pharmaceuticals Portfolio Ownership Of Illumina Inc |
| 2009-11-02 | 2009-08-31 | N-CSRS | Immunogen Inc | IMGN | US | Medical-Biomedical/Gene | 19,100 | New Holding | 19,100 | 100 % | $130,262 | $159,485 | $29,223 | 22.43 % | $29,223 | | | | | | News Article | History of Fidelity Select Portfolios - Pharmaceuticals Portfolio Ownership Of Immunogen Inc |
| 2009-11-02 | 2009-08-31 | N-CSRS | Incyte Corp Ltd | INCY | US | Medical-Biomedical/Gene | 3,000 | New Holding | 3,000 | 100 % | $18,840 | $22,650 | $3,810 | 20.22 % | $3,810 | | | | | | News Article | History of Fidelity Select Portfolios - Pharmaceuticals Portfolio Ownership Of Incyte Corp Ltd |
| 2009-11-02 | 2009-08-31 | N-CSRS | Ista Pharmaceuticals Inc | ISTA | US | Therapeutics | 100 | New Holding | 100 | 100 % | $371 | $419 | $48 | 12.93 % | $48 | | | | | | News Article | History of Fidelity Select Portfolios - Pharmaceuticals Portfolio Ownership Of Ista Pharmaceuticals Inc |
| 2009-11-02 | 2009-08-31 | N-CSRS | Ipc The Hospitalist Co Inc | IPCM | US | Phys Practice Mgmnt | 0 | Sold All | -4,000 | -100 % | - | - | - | 3.14 % | $-3,880 | | | | | | News Article | History of Fidelity Select Portfolios - Pharmaceuticals Portfolio Ownership Of Ipc The Hospitalist Co Inc |
| 2009-11-02 | 2009-08-31 | N-CSRS | Gtx Inc | GTXI | US | Medical-Biomedical/Gene | 2,200 | No Change | 0 | 0 % | $10,032 | $7,722 | $-2,310 | -23.02 % | $0 | | | | | | News Article | History of Fidelity Select Portfolios - Pharmaceuticals Portfolio Ownership Of Gtx Inc |
| 2009-11-02 | 2009-08-31 | N-CSRS | Human Genome Sciences Inc | HGSI | US | Medical-Biomedical/Gene | 15,000 | New Holding | 15,000 | 100 % | $379,200 | $410,700 | $31,500 | 8.30 % | $31,500 | | | | | | News Article | History of Fidelity Select Portfolios - Pharmaceuticals Portfolio Ownership Of Human Genome Sciences Inc |
| 2009-11-02 | 2009-08-31 | N-CSRS | Conceptus Inc | CPTS | US | Medical Instruments | 9,000 | Sold Some | -1,000 | -10.00 % | $158,940 | $154,800 | $-4,140 | -2.60 % | $460 | | | | | | News Article | History of Fidelity Select Portfolios - Pharmaceuticals Portfolio Ownership Of Conceptus Inc |
| 2009-11-02 | 2009-08-31 | N-CSRS | Cadence Pharmaceuticals Inc | CADX | US | Medical-Drugs | 10,600 | No Change | 0 | 0 % | $96,566 | $92,220 | $-4,346 | -4.50 % | $0 | | | | | | News Article | History of Fidelity Select Portfolios - Pharmaceuticals Portfolio Ownership Of Cadence Pharmaceuticals Inc |
| 2009-11-02 | 2009-08-31 | N-CSRS | Vivus Inc | VVUS | US | Therapeutics | 14,000 | Sold Some | -6,000 | -30.00 % | $106,540 | $117,880 | $11,340 | 10.64 % | $-4,860 | | | | | | News Article | History of Fidelity Select Portfolios - Pharmaceuticals Portfolio Ownership Of Vivus Inc |
| 2009-11-02 | 2009-08-31 | N-CSRS | Alexion Pharmaceuticals Inc | ALXN | US | Medical-Biomedical/Gene | 9,436 | Sold Some | -300 | -3.08 % | $410,843 | $412,353 | $1,510 | 0.36 % | $-48 | | | | | | News Article | History of Fidelity Select Portfolios - Pharmaceuticals Portfolio Ownership Of Alexion Pharmaceuticals Inc |
| 2009-11-02 | 2009-08-31 | N-CSRS | Ariad Pharmaceuticals Inc | ARIA | US | Medical-Biomedical/Gene | 10,000 | New Holding | 10,000 | 100 % | $18,200 | $21,600 | $3,400 | 18.68 % | $3,400 | | | | | | News Article | History of Fidelity Select Portfolios - Pharmaceuticals Portfolio Ownership Of Ariad Pharmaceuticals Inc |
| 2009-11-02 | 2009-08-31 | N-CSRS | Acorda Therapeutics Inc | ACOR | US | Medical-Biomedical/Gene | 20,400 | No Change | 0 | 0 % | $448,596 | $487,560 | $38,964 | 8.68 % | $0 | | | | | | News Article | History of Fidelity Select Portfolios - Pharmaceuticals Portfolio Ownership Of Acorda Therapeutics Inc |
| 2009-11-02 | 2009-08-31 | N-CSRS | Auxilium Pharmaceuticals Inc | AUXL | US | Medical-Drugs | 21,700 | No Change | 0 | 0 % | $690,494 | $757,981 | $67,487 | 9.77 % | $0 | | | | | | News Article | History of Fidelity Select Portfolios - Pharmaceuticals Portfolio Ownership Of Auxilium Pharmaceuticals Inc |
| 2009-11-02 | 2009-08-31 | N-CSRS | Avi Biopharma Inc | AVII | US | Therapeutics | 5,000 | New Holding | 5,000 | 100 % | $7,250 | $7,300 | $50 | 0.68 % | $50 | | | | | | News Article | History of Fidelity Select Portfolios - Pharmaceuticals Portfolio Ownership Of Avi Biopharma Inc |
| 2009-11-02 | 2009-08-31 | N-CSRS | Biomarin Pharmaceutical Inc | BMRN | US | Therapeutics | 40,600 | Sold Some | -2,000 | -4.69 % | $631,736 | $688,982 | $57,246 | 9.06 % | $-2,820 | | | | | | News Article | History of Fidelity Select Portfolios - Pharmaceuticals Portfolio Ownership Of Biomarin Pharmaceutical Inc |
| 2009-11-02 | 2009-08-31 | N-CSRS | Biomimetic Therapeutics Inc | BMTI | US | Medical-Biomedical/Gene | 0 | Sold All | -4,000 | -100 % | - | - | - | -1.33 % | $600 | | | | | | News Article | History of Fidelity Select Portfolios - Pharmaceuticals Portfolio Ownership Of Biomimetic Therapeutics Inc |
| 2009-11-02 | 2009-08-31 | N-CSRS | Align Technology Inc | ALGN | US | Dental Supplies And Equip | 18,100 | Sold Some | -13,000 | -41.80 % | $290,505 | $281,274 | $-9,231 | -3.17 % | $6,630 | | | | | | News Article | History of Fidelity Select Portfolios - Pharmaceuticals Portfolio Ownership Of Align Technology Inc |
| 2009-11-02 | 2009-08-31 | N-CSRS | Cardiome Pharma Corp | CRME | CA | Medical-Drugs | 5,000 | New Holding | 5,000 | 100 % | $19,100 | $18,650 | $-450 | -2.35 % | $-450 | | | | | | News Article | History of Fidelity Select Portfolios - Pharmaceuticals Portfolio Ownership Of Cardiome Pharma Corp |
| 2009-11-02 | 2009-08-31 | N-CSRS | Allos Therapeutics Inc | ALTH | US | Therapeutics | 6,600 | Sold Some | -500 | -7.04 % | $37,884 | $40,656 | $2,772 | 7.31 % | $-210 | | | | | | News Article | History of Fidelity Select Portfolios - Pharmaceuticals Portfolio Ownership Of Allos Therapeutics Inc |
| 2009-11-02 | 2009-08-31 | N-CSRS | Forest Laboratories Inc | FRX | US | Medical-Drugs | 57,520 | Added More | 57,400 | 47833.33 % | $1,580,650 | $1,700,866 | $120,217 | 7.60 % | $119,966 | | | | | | News Article | History of Fidelity Select Portfolios - Pharmaceuticals Portfolio Ownership Of Forest Laboratories Inc |
| 2009-11-02 | 2009-08-31 | N-CSRS | Community Health Systems Inc | CYH | US | Medical-Hospitals | 2,000 | Sold Some | -800 | -28.57 % | $65,580 | $61,560 | $-4,020 | -6.12 % | $1,608 | | | | | | News Article | History of Fidelity Select Portfolios - Pharmaceuticals Portfolio Ownership Of Community Health Systems Inc |
| 2009-11-02 | 2009-08-31 | N-CSRS | Danaher Corp | DHR | US | Diversified Manufact Op | 5,100 | Sold Some | -1,700 | -25.00 % | $349,605 | $365,568 | $15,963 | 4.56 % | $-5,321 | | | | | | News Article | History of Fidelity Select Portfolios - Pharmaceuticals Portfolio Ownership Of Danaher Corp |
| 2009-11-02 | 2009-08-31 | N-CSRS | Cigna Corp | CI | US | Life/Health Insurance | 27,800 | Added More | 12,800 | 85.33 % | $779,234 | $834,834 | $55,600 | 7.13 % | $25,600 | | | | | | News Article | History of Fidelity Select Portfolios - Pharmaceuticals Portfolio Ownership Of Cigna Corp |
| 2009-11-02 | 2009-08-31 | N-CSRS | Baxter International Inc | BAX | US | Medical Products | 1,400 | Sold Some | -11,600 | -89.23 % | $76,370 | $76,062 | $-308 | -0.40 % | $2,552 | | | | | | News Article | History of Fidelity Select Portfolios - Pharmaceuticals Portfolio Ownership Of Baxter International Inc |
| 2009-11-02 | 2009-08-31 | N-CSRS | Mylan Incpa | MYL | US | Medical-Generic Drugs | 76,100 | Added More | 76,000 | 76000.00 % | $1,245,757 | $1,335,555 | $89,798 | 7.20 % | $89,680 | | | | | | News Article | History of Fidelity Select Portfolios - Pharmaceuticals Portfolio Ownership Of Mylan Incpa |
| 2009-11-02 | 2009-08-31 | N-CSRS | Humana Inc | HUM | US | Medical-Hmo | 13,600 | Sold Some | -600 | -4.22 % | $503,336 | $549,984 | $46,648 | 9.26 % | $-2,058 | | | | | | News Article | History of Fidelity Select Portfolios - Pharmaceuticals Portfolio Ownership Of Humana Inc |
| 2009-11-02 | 2009-08-31 | N-CSRS | Emeritus Corp | ESC | US | Retirement/Aged Care | 0 | Sold All | -14,000 | -100 % | - | - | - | -18.34 % | $51,660 | | | | | | News Article | History of Fidelity Select Portfolios - Pharmaceuticals Portfolio Ownership Of Emeritus Corp |
| 2009-11-02 | 2009-08-31 | N-CSRS | Brookdale Senior Living Inc | BKD | US | Retirement/Aged Care | 0 | Sold All | -18,500 | -100 % | - | - | - | -6.92 % | $22,015 | | | | | | News Article | History of Fidelity Select Portfolios - Pharmaceuticals Portfolio Ownership Of Brookdale Senior Living Inc |
| 2009-11-02 | 2009-08-31 | N-CSRS | Questcor Pharmaceuticals Inc | QSC | US | Therapeutics | 14,400 | Added More | 6,000 | 71.42 % | - | - | - | - % | | | | | | | News Article | History of Fidelity Select Portfolios - Pharmaceuticals Portfolio Ownership Of Questcor Pharmaceuticals Inc |
| 2009-11-02 | 2009-08-31 | N-CSRS | Qiagen Nv | QGEN | DE | Medical-Biomedical/Gene | 42,877 | Sold Some | -12,600 | -22.71 % | $884,981 | $922,284 | $37,303 | 4.21 % | $-10,962 | | | | | | News Article | History of Fidelity Select Portfolios - Pharmaceuticals Portfolio Ownership Of Qiagen Nv |
| 2009-11-02 | 2009-08-31 | N-CSRS | Micromet Inc | MITI | DE | Medical-Biomedical/Gene | 3,000 | New Holding | 3,000 | 100 % | $15,630 | $20,700 | $5,070 | 32.43 % | $5,070 | | | | | | News Article | History of Fidelity Select Portfolios - Pharmaceuticals Portfolio Ownership Of Micromet Inc |
| 2009-11-02 | 2009-08-31 | N-CSRS | King Pharmaceuticals Inc | KG | US | Medical-Drugs | 139,100 | Added More | 31,500 | 29.27 % | $1,417,429 | $1,641,380 | $223,951 | 15.79 % | $50,715 | | | | | | News Article | History of Fidelity Select Portfolios - Pharmaceuticals Portfolio Ownership Of King Pharmaceuticals Inc |
| 2009-11-02 | 2009-08-31 | N-CSRS | Covidien Ltd | COV | BM | Medical Products | 48,800 | Added More | 11,700 | 31.53 % | $2,094,008 | $2,227,720 | $133,712 | 6.38 % | $32,058 | | | | | | News Article | History of Fidelity Select Portfolios - Pharmaceuticals Portfolio Ownership Of Covidien Ltd |
| 2009-11-02 | 2009-08-31 | N-CSRS | Xenoport Inc | XNPT | US | Medical-Drugs | 22,300 | No Change | 0 | 0 % | $377,316 | $364,605 | $-12,711 | -3.36 % | $0 | | | | | | News Article | History of Fidelity Select Portfolios - Pharmaceuticals Portfolio Ownership Of Xenoport Inc |
| 2009-11-02 | 2009-08-31 | N-CSRS | Javelin Pharmaceuticals Inc | JAV | US | Medical-Drugs | 0 | Sold All | -5,000 | -100 % | - | - | - | 8.08 % | $-550 | | | | | | News Article | History of Fidelity Select Portfolios - Pharmaceuticals Portfolio Ownership Of Javelin Pharmaceuticals Inc |
| 2009-11-02 | 2009-08-31 | N-CSRS | Biodel Inc | BIOD | US | Medical-Drugs | 15,000 | Added More | 10,000 | 200.00 % | $62,100 | $62,250 | $150 | 0.24 % | $100 | | | | | | News Article | History of Fidelity Select Portfolios - Pharmaceuticals Portfolio Ownership Of Biodel Inc |
| 2009-11-02 | 2009-08-31 | N-CSRS | Resmed Inc | RMD | US | Respiratory Products | 100 | No Change | 0 | 0 % | $4,957 | $5,025 | $68 | 1.37 % | $0 | | | | | | News Article | History of Fidelity Select Portfolios - Pharmaceuticals Portfolio Ownership Of Resmed Inc |
| 2009-11-02 | 2009-08-31 | N-CSRS | Rigel Pharmaceuticals Inc | RIGL | US | Medical-Drugs | 5,000 | No Change | 0 | 0 % | $32,750 | $38,900 | $6,150 | 18.77 % | $0 | | | | | | News Article | History of Fidelity Select Portfolios - Pharmaceuticals Portfolio Ownership Of Rigel Pharmaceuticals Inc |
| 2009-11-02 | 2009-08-31 | N-CSRS | Vical Inc | VICL | BE | Medical-Biomedical/Gene | 1,000 | New Holding | 1,000 | 100 % | $3,090 | $3,070 | $-20 | -0.64 % | $-20 | | | | | | News Article | History of Fidelity Select Portfolios - Pharmaceuticals Portfolio Ownership Of Vical Inc |
| 2009-11-02 | 2009-08-31 | N-CSRS | Vanda Pharmaceuticals Inc | VNDA | US | Therapeutics | 250,800 | No Change | 0 | 0 % | $2,508,000 | $2,578,224 | $70,224 | 2.80 % | $0 | | | | | | News Article | History of Fidelity Select Portfolios - Pharmaceuticals Portfolio Ownership Of Vanda Pharmaceuticals Inc |
| 2009-11-02 | 2009-08-31 | N-CSRS | Salix Pharmaceuticals Ltd | SLXP | US | Medical-Drugs | 20,000 | New Holding | 20,000 | 100 % | $380,200 | $468,200 | $88,000 | 23.14 % | $88,000 | | | | | | News Article | History of Fidelity Select Portfolios - Pharmaceuticals Portfolio Ownership Of Salix Pharmaceuticals Ltd |
| 2009-11-02 | 2009-08-31 | N-CSRS | Nuvasive Inc | NUVA | US | Medical Instruments | 6,500 | No Change | 0 | 0 % | $227,825 | $219,700 | $-8,125 | -3.56 % | $0 | | | | | | News Article | History of Fidelity Select Portfolios - Pharmaceuticals Portfolio Ownership Of Nuvasive Inc |
| 2009-11-02 | 2009-08-31 | N-CSRS | Novavax Inc | NVAX | US | Medical-Biomedical/Gene | 1,000 | New Holding | 1,000 | 100 % | $3,810 | $3,280 | $-530 | -13.91 % | $-530 | | | | | | News Article | History of Fidelity Select Portfolios - Pharmaceuticals Portfolio Ownership Of Novavax Inc |
| 2009-11-02 | 2009-08-31 | N-CSRS | Pharmaxis Ltd | PXSL | AU | Therapeutics | 10,000 | New Holding | 10,000 | 100 % | - | - | - | - % | | | | | | | News Article | History of Fidelity Select Portfolios - Pharmaceuticals Portfolio Ownership Of Pharmaxis Ltd |
| 2009-11-02 | 2009-08-31 | N-CSRS | Ardea Biosciences Inc | RDEA | US | Medical-Drugs | 10,000 | New Holding | 10,000 | 100 % | $134,200 | $136,800 | $2,600 | 1.93 % | $2,600 | | | | | | News Article | History of Fidelity Select Portfolios - Pharmaceuticals Portfolio Ownership Of Ardea Biosciences Inc |
| 2009-11-02 | 2009-08-31 | N-CSRS | Onyx Pharmaceuticals Inc | ONXX | US | Therapeutics | 1,500 | Sold Some | -9,000 | -85.71 % | $39,675 | $41,985 | $2,310 | 5.82 % | $-13,860 | | | | | | News Article | History of Fidelity Select Portfolios - Pharmaceuticals Portfolio Ownership Of Onyx Pharmaceuticals Inc |
| 2009-11-02 | 2009-08-31 | N-CSRS | Optimer Pharmaceuticals Inc | OPTR | US | Medical-Biomedical/Gene | 6,000 | New Holding | 6,000 | 100 % | $69,780 | $72,000 | $2,220 | 3.18 % | $2,220 | | | | | | News Article | History of Fidelity Select Portfolios - Pharmaceuticals Portfolio Ownership Of Optimer Pharmaceuticals Inc |
| 2009-11-02 | 2009-08-31 | N-CSRS | Orexigen Therapeutics Inc | OREX | US | Medical-Biomedical/Gene | 4,000 | Sold Some | -1,000 | -20.00 % | $26,920 | $27,480 | $560 | 2.08 % | $-140 | | | | | | News Article | History of Fidelity Select Portfolios - Pharmaceuticals Portfolio Ownership Of Orexigen Therapeutics Inc |
| 2009-11-02 | 2009-08-31 | N-CSRS | Medarex Inc | MEDX | US | Therapeutics | 0 | Sold All | -2,000 | -100 % | - | - | - | - % | | | | | | | News Article | History of Fidelity Select Portfolios - Pharmaceuticals Portfolio Ownership Of Medarex Inc |
| 2009-11-02 | 2009-08-31 | N-CSRS | Micrus Endovascular Corp | MEND | US | Medical Instruments | 23,000 | No Change | 0 | 0 % | $263,120 | $298,080 | $34,960 | 13.28 % | $0 | | | | | | News Article | History of Fidelity Select Portfolios - Pharmaceuticals Portfolio Ownership Of Micrus Endovascular Corp |
| 2009-11-02 | 2009-08-31 | N-CSRS | Momenta Pharmaceuticals Inc | MNTA | US | Medical-Biomedical/Gene | 2,700 | Sold Some | -1,300 | -32.50 % | $24,030 | $29,835 | $5,805 | 24.15 % | $-2,795 | | | | | | News Article | History of Fidelity Select Portfolios - Pharmaceuticals Portfolio Ownership Of Momenta Pharmaceuticals Inc |
| 2009-11-02 | 2009-08-31 | N-CSRS | Abiomed Inc | ABMD | US | Medical Products | 25,000 | New Holding | 25,000 | 100 % | $221,250 | $203,500 | $-17,750 | -8.02 % | $-17,750 | | | | | | News Article | History of Fidelity Select Portfolios - Pharmaceuticals Portfolio Ownership Of Abiomed Inc |
| 2009-11-02 | 2009-08-31 | N-CSRS | Dendreon Corp | DNDN | US | Therapeutics | 17,000 | No Change | 0 | 0 % | $431,800 | $476,170 | $44,370 | 10.27 % | $0 | | | | | | News Article | History of Fidelity Select Portfolios - Pharmaceuticals Portfolio Ownership Of Dendreon Corp |
| 2009-11-02 | 2009-08-31 | N-CSRS | Bristol-Myers Squibb Co | BMY | BE | Medical-Drugs | 183,400 | Sold Some | -13,900 | -7.04 % | $3,992,618 | $4,485,964 | $493,346 | 12.35 % | $-37,391 | | | | | | News Article | History of Fidelity Select Portfolios - Pharmaceuticals Portfolio Ownership Of Bristol-Myers Squibb Co |
| 2009-11-02 | 2009-08-31 | N-CSRS | Csl Ltdaustralia | CMXHF.OB | AU | Medical-Biomedical/Gene | 5,467 | Sold Some | -11,500 | -67.77 % | - | - | - | - % | | | | | | | News Article | History of Fidelity Select Portfolios - Pharmaceuticals Portfolio Ownership Of Csl Ltdaustralia |
| 2009-11-02 | 2009-08-31 | N-CSRS | Masimo Corp | MASI | US | Patient Monitoring Equip | 17,330 | Sold Some | -10,500 | -37.72 % | $460,458 | $465,657 | $5,199 | 1.12 % | $-3,150 | | | | | | News Article | History of Fidelity Select Portfolios - Pharmaceuticals Portfolio Ownership Of Masimo Corp |
| 2009-11-02 | 2009-08-31 | N-CSRS | Ranbaxy Laboratories Ltd | RBXLF.PK | US | Medical-Drugs | 10,000 | New Holding | 10,000 | 100 % | - | - | - | - % | | | | | | | News Article | History of Fidelity Select Portfolios - Pharmaceuticals Portfolio Ownership Of Ranbaxy Laboratories Ltd |
| 2009-11-02 | 2009-08-31 | N-CSRS | Mako Surgical Corp | MAKO | US | Medical Instruments | 13,000 | No Change | 0 | 0 % | $117,910 | $114,400 | $-3,510 | -2.97 % | $0 | | | | | | News Article | History of Fidelity Select Portfolios - Pharmaceuticals Portfolio Ownership Of Mako Surgical Corp |
| 2009-11-02 | 2009-08-31 | N-CSRS | Map Pharmaceuticals Inc | MAPP | US | Medical-Drugs | 27,112 | Added More | 24,712 | 1029.66 % | $219,065 | $237,230 | $18,165 | 8.29 % | $16,557 | | | | | | News Article | History of Fidelity Select Portfolios - Pharmaceuticals Portfolio Ownership Of Map Pharmaceuticals Inc |
| 2009-11-02 | 2009-08-31 | N-CSRS | Alcon Inc | ACL | CH | Optical Supplies | 4,000 | Sold Some | -2,000 | -33.33 % | $569,160 | $581,040 | $11,880 | 2.08 % | $-5,940 | | | | | | News Article | History of Fidelity Select Portfolios - Pharmaceuticals Portfolio Ownership Of Alcon Inc |
| 2009-11-02 | 2009-08-31 | N-CSRS | Quidel Corp | QDEL | US | Diagnostic Kits | 12,100 | No Change | 0 | 0 % | $172,788 | $160,083 | $-12,705 | -7.35 % | $0 | | | | | | News Article | History of Fidelity Select Portfolios - Pharmaceuticals Portfolio Ownership Of Quidel Corp |
| 2009-11-02 | 2009-08-31 | N-CSRS | Icu Medical Inc | ICUI | US | Disposable Medical Prod | 900 | Added More | 600 | 200.00 % | $30,726 | $30,222 | $-504 | -1.64 % | $-336 | | | | | | News Article | History of Fidelity Select Portfolios - Pharmaceuticals Portfolio Ownership Of Icu Medical Inc |
| 2009-11-02 | 2009-08-31 | N-CSRS | Dentsply International Inc | XRAY | US | Dental Supplies And Equip | 5,000 | No Change | 0 | 0 % | $165,050 | $164,300 | $-750 | -0.45 % | $0 | | | | | | News Article | History of Fidelity Select Portfolios - Pharmaceuticals Portfolio Ownership Of Dentsply International Inc |
| 2009-11-02 | 2009-08-31 | N-CSRS | Bruker Corp | BRKR | US | Medical Instruments | 20,000 | No Change | 0 | 0 % | $219,200 | $231,000 | $11,800 | 5.38 % | $0 | | | | | | News Article | History of Fidelity Select Portfolios - Pharmaceuticals Portfolio Ownership Of Bruker Corp |
| 2009-11-02 | 2009-08-31 | N-CSRS | Osi Pharmaceuticals Inc | OSIP | US | Medical-Drugs | 500 | Sold Some | -1,500 | -75.00 % | $16,425 | $16,395 | $-30 | -0.18 % | $90 | | | | | | News Article | History of Fidelity Select Portfolios - Pharmaceuticals Portfolio Ownership Of Osi Pharmaceuticals Inc |
| 2009-11-02 | 2009-08-31 | N-CSRS | Medicines Cothe | MDCO | US | Therapeutics | 0 | Sold All | -31,600 | -100 % | - | - | - | 3.31 % | $-7,584 | | | | | | News Article | History of Fidelity Select Portfolios - Pharmaceuticals Portfolio Ownership Of Medicines Cothe |
| 2009-11-02 | 2009-08-31 | N-CSRS | Meridian Bioscience Inc | VIVO | US | Diagnostic Kits | 11,400 | Sold Some | -300 | -2.56 % | $252,168 | $237,690 | $-14,478 | -5.74 % | $381 | | | | | | News Article | History of Fidelity Select Portfolios - Pharmaceuticals Portfolio Ownership Of Meridian Bioscience Inc |
| 2009-11-02 | 2009-08-31 | N-CSRS | Henry Schein Inc | HSIC | US | Medical Products | 10,800 | Added More | 2,000 | 22.72 % | $578,556 | $545,724 | $-32,832 | -5.67 % | $-6,080 | | | | | | News Article | History of Fidelity Select Portfolios - Pharmaceuticals Portfolio Ownership Of Henry Schein Inc |
| 2009-11-02 | 2009-08-31 | N-CSRS | Sepracor Inc | SEPR | US | Medical-Drugs | 100 | No Change | 0 | 0 % | - | - | - | - % | | | | | | | News Article | History of Fidelity Select Portfolios - Pharmaceuticals Portfolio Ownership Of Sepracor Inc |
| 2009-11-02 | 2009-08-31 | N-CSRS | Perrigo Co | PRGO | IL | Medical-Generic Drugs | 19,200 | Sold Some | -16,700 | -46.51 % | $731,520 | $754,752 | $23,232 | 3.17 % | $-20,207 | | | | | | News Article | History of Fidelity Select Portfolios - Pharmaceuticals Portfolio Ownership Of Perrigo Co |
| 2009-11-02 | 2009-08-31 | N-CSRS | Cvscaremark Corp | CVS | US | Retail-Drug Store | 19,900 | Added More | 3,900 | 24.37 % | $711,425 | $629,636 | $-81,789 | -11.49 % | $-16,029 | | | | | | News Article | History of Fidelity Select Portfolios - Pharmaceuticals Portfolio Ownership Of Cvscaremark Corp |
| 2009-11-02 | 2009-08-31 | N-CSRS | Noven Pharmaceuticals Inc | NOVN | US | Drug Delivery Systems | 0 | Sold All | -6,000 | -100 % | - | - | - | - % | | | | | | | News Article | History of Fidelity Select Portfolios - Pharmaceuticals Portfolio Ownership Of Noven Pharmaceuticals Inc |
| 2009-11-02 | 2009-08-31 | N-CSRS | Allergan Incunited States | AGN | US | Medical-Drugs | 140,800 | Sold Some | -3,500 | -2.42 % | $8,079,104 | $8,253,696 | $174,592 | 2.16 % | $-4,340 | | | | | | News Article | History of Fidelity Select Portfolios - Pharmaceuticals Portfolio Ownership Of Allergan Incunited States |
| 2009-11-02 | 2009-08-31 | N-CSRS | Amylin Pharmaceuticals Inc | AMLN | US | Therapeutics | 21,360 | Sold Some | -1,000 | -4.47 % | $259,097 | $265,718 | $6,622 | 2.55 % | $-310 | | | | | | News Article | History of Fidelity Select Portfolios - Pharmaceuticals Portfolio Ownership Of Amylin Pharmaceuticals Inc |
| 2009-11-02 | 2009-08-31 | N-CSRS | Celgene Corp | CELG | US | Medical-Biomedical/Gene | 0 | Sold All | -3,700 | -100 % | - | - | - | 9.36 % | $-17,390 | | | | | | News Article | History of Fidelity Select Portfolios - Pharmaceuticals Portfolio Ownership Of Celgene Corp |
| 2009-11-02 | 2009-08-31 | N-CSRS | Genzyme Corp | GENZ | US | Medical-Biomedical/Gene | 12,000 | New Holding | 12,000 | 100 % | $603,840 | $600,600 | $-3,240 | -0.53 % | $-3,240 | | | | | | News Article | History of Fidelity Select Portfolios - Pharmaceuticals Portfolio Ownership Of Genzyme Corp |
| 2009-11-02 | 2009-08-31 | N-CSRS | Gilead Sciences Inc | GILD | US | Therapeutics | 0 | Sold All | -3,400 | -100 % | - | - | - | 8.71 % | $-12,648 | | | | | | News Article | History of Fidelity Select Portfolios - Pharmaceuticals Portfolio Ownership Of Gilead Sciences Inc |
| 2009-11-02 | 2009-08-31 | N-CSRS | Edwards Lifesciences Corp | EW | US | Medical Instruments | 7,000 | No Change | 0 | 0 % | $544,810 | $568,750 | $23,940 | 4.39 % | $0 | | | | | | News Article | History of Fidelity Select Portfolios - Pharmaceuticals Portfolio Ownership Of Edwards Lifesciences Corp |
| 2009-11-02 | 2009-08-31 | N-CSRS | Intuitive Surgical Inc | ISRG | US | Medical Instruments | 0 | Sold All | -100 | -100 % | - | - | - | 12.20 % | $-3,006 | | | | | | News Article | History of Fidelity Select Portfolios - Pharmaceuticals Portfolio Ownership Of Intuitive Surgical Inc |
| 2009-11-02 | 2009-08-31 | N-CSRS | Myriad Genetics Inc | MYGN | US | Medical-Biomedical/Gene | 20,700 | Sold Some | -4,900 | -19.14 % | $512,739 | $488,520 | $-24,219 | -4.72 % | $5,733 | | | | | | News Article | History of Fidelity Select Portfolios - Pharmaceuticals Portfolio Ownership Of Myriad Genetics Inc |
| 2009-11-02 | 2009-08-31 | N-CSRS | Hospira Inc | HSP | US | Drug Delivery Systems | 8,000 | New Holding | 8,000 | 100 % | $359,200 | $375,040 | $15,840 | 4.40 % | $15,840 | | | | | | News Article | History of Fidelity Select Portfolios - Pharmaceuticals Portfolio Ownership Of Hospira Inc |
| 2009-11-02 | 2009-08-31 | N-CSRS | Johnson And Johnson | JNJ | US | Medical Products | 429,300 | Sold Some | -14,500 | -3.26 % | $25,539,057 | $26,749,683 | $1,210,626 | 4.74 % | $-40,890 | | | | | | News Article | History of Fidelity Select Portfolios - Pharmaceuticals Portfolio Ownership Of Johnson And Johnson |
| 2009-11-02 | 2009-08-31 | N-CSRS | Hanger Orthopedic Group Inc | HGR | US | Medical Products | 9,500 | No Change | 0 | 0 % | $130,910 | $126,065 | $-4,845 | -3.70 % | $0 | | | | | | News Article | History of Fidelity Select Portfolios - Pharmaceuticals Portfolio Ownership Of Hanger Orthopedic Group Inc |
| 2009-11-02 | 2009-08-31 | N-CSRS | Health Net Inc | HNT | US | Medical-Hmo | 0 | Sold All | -18,000 | -100 % | - | - | - | 32.04 % | $-87,840 | | | | | | News Article | History of Fidelity Select Portfolios - Pharmaceuticals Portfolio Ownership Of Health Net Inc |
| 2009-11-02 | 2009-08-31 | N-CSRS | Prestige Brands Holdings Inc | PBH | US | Consumer Products-Misc | 0 | Sold All | -2,500 | -100 % | - | - | - | 3.22 % | $-550 | | | | | | News Article | History of Fidelity Select Portfolios - Pharmaceuticals Portfolio Ownership Of Prestige Brands Holdings Inc |
| 2009-11-02 | 2009-08-31 | N-CSRS | United Therapeutics Corp | UTHR | US | Therapeutics | 16,800 | Added More | 11,000 | 189.65 % | $710,136 | $754,488 | $44,352 | 6.24 % | $29,040 | | | | | | News Article | History of Fidelity Select Portfolios - Pharmaceuticals Portfolio Ownership Of United Therapeutics Corp |
| 2009-11-02 | 2009-08-31 | N-CSRS | Medco Health Solutions Inc | MHS | US | Pharmacy Services | 51,400 | Sold Some | -10,400 | -16.82 % | $2,959,612 | $3,166,754 | $207,142 | 6.99 % | $-41,912 | | | | | | News Article | History of Fidelity Select Portfolios - Pharmaceuticals Portfolio Ownership Of Medco Health Solutions Inc |
| 2009-11-02 | 2009-08-31 | N-CSRS | Sonova Holding Ag | SONVF.PK | CH | Medical Products | 2,827 | Sold Some | -1,300 | -31.49 % | - | - | - | - % | | | | | | | News Article | History of Fidelity Select Portfolios - Pharmaceuticals Portfolio Ownership Of Sonova Holding Ag |
| 2009-11-02 | 2009-08-31 | N-CSRS | Impax Laboratories Inc | IPXL.PK | US | Medical-Generic Drugs | 41,100 | Added More | 19,100 | 86.81 % | - | - | - | - % | | | | | | | News Article | History of Fidelity Select Portfolios - Pharmaceuticals Portfolio Ownership Of Impax Laboratories Inc |
| 2009-11-02 | 2009-08-31 | N-CSRS | Intercell Ag | INRLF.PK | DE | Medical-Biomedical/Gene | 100 | No Change | 0 | 0 % | - | - | - | - % | | | | | | | News Article | History of Fidelity Select Portfolios - Pharmaceuticals Portfolio Ownership Of Intercell Ag |
| 2009-11-02 | 2009-08-31 | N-CSRS | Newron Pharmaceuticals Spa | NP5.BE | IT | Therapeutics | 1,000 | New Holding | 1,000 | 100 % | - | - | - | - % | | | | | | | News Article | History of Fidelity Select Portfolios - Pharmaceuticals Portfolio Ownership Of Newron Pharmaceuticals Spa |
| 2009-11-02 | 2009-08-31 | N-CSRS | Protalix Biotherapeutics Inc | PLX | US | Medical-Biomedical/Gene | 3,000 | New Holding | 3,000 | 100 % | $31,290 | $30,030 | $-1,260 | -4.02 % | $-1,260 | | | | | | News Article | History of Fidelity Select Portfolios - Pharmaceuticals Portfolio Ownership Of Protalix Biotherapeutics Inc |
| 2009-11-02 | 2009-08-31 | N-CSRS | Inspire Pharmaceuticals Inc | ISPH | US | Therapeutics | 8,500 | Added More | 5,500 | 183.33 % | $38,675 | $42,840 | $4,165 | 10.76 % | $2,695 | | | | | | News Article | History of Fidelity Select Portfolios - Pharmaceuticals Portfolio Ownership Of Inspire Pharmaceuticals Inc |
| 2009-11-02 | 2009-08-31 | N-CSRS | Actelion Ltd | ALIOF.OB | CH | Medical-Drugs | 132 | No Change | 0 | 0 % | - | - | - | - % | | | | | | | News Article | History of Fidelity Select Portfolios - Pharmaceuticals Portfolio Ownership Of Actelion Ltd |
| 2009-11-02 | 2009-08-31 | N-CSRS | Oncogenex Pharmaceuticals Inc | OGXI | US | Medical-Biomedical/Gene | 4,000 | No Change | 0 | 0 % | $107,960 | $129,280 | $21,320 | 19.74 % | $0 | | | | | | News Article | History of Fidelity Select Portfolios - Pharmaceuticals Portfolio Ownership Of Oncogenex Pharmaceuticals Inc |
| 2009-11-02 | 2009-08-31 | N-CSRS | Tenet Healthcare Corp | THC | US | Medical-Hospitals | 10,000 | New Holding | 10,000 | 100 % | $53,000 | $52,700 | $-300 | -0.56 % | $-300 | | | | | | News Article | History of Fidelity Select Portfolios - Pharmaceuticals Portfolio Ownership Of Tenet Healthcare Corp |
| 2009-11-02 | 2009-08-31 | N-CSRS | Monsanto Co | MON | US | Agricultural Chemicals | 0 | Sold All | -4,350 | -100 % | - | - | - | 17.28 % | $-51,330 | | | | | | News Article | History of Fidelity Select Portfolios - Pharmaceuticals Portfolio Ownership Of Monsanto Co |
| 2009-11-02 | 2009-08-31 | N-CSRS | Athenahealth Inc | ATHN | US | Phys Practice Mgmnt | 0 | Sold All | -2,700 | -100 % | - | - | - | 5.67 % | $-6,129 | | | | | | News Article | History of Fidelity Select Portfolios - Pharmaceuticals Portfolio Ownership Of Athenahealth Inc |
| 2009-11-02 | 2009-08-31 | N-CSRS | Cardionet Inc | BEAT | US | Patient Monitoring Equip | 0 | Sold All | -5,000 | -100 % | - | - | - | -4.73 % | $1,250 | | | | | | News Article | History of Fidelity Select Portfolios - Pharmaceuticals Portfolio Ownership Of Cardionet Inc |
| 2009-11-02 | 2009-08-31 | N-CSRS | Syneron Medical Ltd | ELOS | IL | Medical Products | 0 | Sold All | -2,000 | -100 % | - | - | - | -7.51 % | $1,660 | | | | | | News Article | History of Fidelity Select Portfolios - Pharmaceuticals Portfolio Ownership Of Syneron Medical Ltd |
| 2009-11-02 | 2009-08-31 | N-CSRS | Warner Chilcott Ltd | WCRX | BM | Therapeutics | 60,900 | Added More | 35,800 | 142.62 % | $1,398,264 | $1,399,482 | $1,218 | 0.08 % | $716 | | | | | | News Article | History of Fidelity Select Portfolios - Pharmaceuticals Portfolio Ownership Of Warner Chilcott Ltd |
| 2009-11-02 | 2009-08-31 | N-CSRS | Vertex Pharmaceuticals Inc | VRTX | US | Medical-Biomedical/Gene | 0 | Sold All | -180 | -100 % | - | - | - | 6.61 % | $-430 | | | | | | News Article | History of Fidelity Select Portfolios - Pharmaceuticals Portfolio Ownership Of Vertex Pharmaceuticals Inc |
| 2009-11-02 | 2009-08-31 | N-CSRS | Viropharma Inc | VPHM | US | Medical-Drugs | 48,200 | Added More | 500 | 1.04 % | $351,860 | $371,140 | $19,280 | 5.47 % | $200 | | | | | | News Article | History of Fidelity Select Portfolios - Pharmaceuticals Portfolio Ownership Of Viropharma Inc |
| 2009-11-02 | 2009-08-31 | N-CSRS | Techne Corp | TECH | US | Medical Instruments | 466 | Sold Some | -300 | -39.16 % | $29,307 | $31,278 | $1,971 | 6.72 % | $-1,269 | | | | | | News Article | History of Fidelity Select Portfolios - Pharmaceuticals Portfolio Ownership Of Techne Corp |
| 2009-11-02 | 2009-08-31 | N-CSRS | Express Scripts Inc | ESRX | US | Pharmacy Services | 25,000 | Added More | 300 | 1.21 % | $2,073,750 | $2,127,250 | $53,500 | 2.57 % | $642 | | | | | | News Article | History of Fidelity Select Portfolios - Pharmaceuticals Portfolio Ownership Of Express Scripts Inc |
| 2009-11-02 | 2009-08-31 | N-CSRS | Chattem Inc | CHTT | US | Cosmetics And Toiletries | 8,200 | Sold Some | -1,500 | -15.46 % | $522,258 | $544,808 | $22,550 | 4.31 % | $-4,125 | | | | | | News Article | History of Fidelity Select Portfolios - Pharmaceuticals Portfolio Ownership Of Chattem Inc |
| 2009-11-02 | 2009-08-31 | N-CSRS | Biogen Idec Inc | BIIB | US | Medical-Biomedical/Gene | 20,100 | Sold Some | -6,600 | -24.71 % | $856,059 | $932,238 | $76,179 | 8.89 % | $-25,014 | | | | | | News Article | History of Fidelity Select Portfolios - Pharmaceuticals Portfolio Ownership Of Biogen Idec Inc |
| 2009-11-02 | 2009-08-31 | N-CSRS | Ev3 Inc | EVVV | US | Medical Instruments | 10,000 | No Change | 0 | 0 % | $117,800 | $126,000 | $8,200 | 6.96 % | $0 | | | | | | News Article | History of Fidelity Select Portfolios - Pharmaceuticals Portfolio Ownership Of Ev3 Inc |
| 2009-11-02 | 2009-08-31 | N-CSRS | Shire Plc | SHPGY | DE | Medical-Drugs | 60,052 | Added More | 58,552 | 3903.46 % | $3,152,129 | $3,388,734 | $236,605 | 7.50 % | $230,695 | | | | | | News Article | History of Fidelity Select Portfolios - Pharmaceuticals Portfolio Ownership Of Shire Plc |
| 2009-11-02 | 2009-08-31 | N-CSRS | Unitedhealth Group Inc | UNH | US | Medical-Hmo | 18,200 | New Holding | 18,200 | 100 % | $480,844 | $519,792 | $38,948 | 8.09 % | $38,948 | | | | | | News Article | History of Fidelity Select Portfolios - Pharmaceuticals Portfolio Ownership Of Unitedhealth Group Inc |
| 2009-11-02 | 2009-08-31 | N-CSRS | Aetna Inc | AET | US | Medical-Hmo | 19,000 | New Holding | 19,000 | 100 % | $499,130 | $539,600 | $40,470 | 8.10 % | $40,470 | | | | | | News Article | History of Fidelity Select Portfolios - Pharmaceuticals Portfolio Ownership Of Aetna Inc |
| 2009-11-02 | 2009-08-31 | N-CSRS | Agilent Technologies Inc | A | US | Electronic Measur Instr | 27,500 | Added More | 12,500 | 83.33 % | $689,425 | $795,025 | $105,600 | 15.31 % | $48,000 | | | | | | News Article | History of Fidelity Select Portfolios - Pharmaceuticals Portfolio Ownership Of Agilent Technologies Inc |
| 2009-11-02 | 2009-08-31 | N-CSRS | Abbott Laboratories | ABT | US | Medical-Drugs | 310,200 | Added More | 13,000 | 4.37 % | $15,792,282 | $16,639,128 | $846,846 | 5.36 % | $35,490 | | | | | | News Article | History of Fidelity Select Portfolios - Pharmaceuticals Portfolio Ownership Of Abbott Laboratories |
| 2009-11-02 | 2009-08-31 | N-CSRS | Cr Bard Inc | BCR | US | Disposable Medical Prod | 14,600 | Sold Some | -500 | -3.31 % | $1,107,848 | $1,178,512 | $70,664 | 6.37 % | $-2,420 | | | | | | News Article | History of Fidelity Select Portfolios - Pharmaceuticals Portfolio Ownership Of Cr Bard Inc |
| 2009-11-02 | 2009-08-31 | N-CSRS | Coventry Health Care Inc | CVH | US | Medical-Hmo | 2,000 | New Holding | 2,000 | 100 % | $41,800 | $45,080 | $3,280 | 7.84 % | $3,280 | | | | | | News Article | History of Fidelity Select Portfolios - Pharmaceuticals Portfolio Ownership Of Coventry Health Care Inc |
| 2009-11-02 | 2009-08-31 | N-CSRS | Amgen Inc | AMGN | US | Medical-Biomedical/Gene | 0 | Sold All | -2,900 | -100 % | - | - | - | 5.62 % | $-8,555 | | | | | | News Article | History of Fidelity Select Portfolios - Pharmaceuticals Portfolio Ownership Of Amgen Inc |
| 2009-11-02 | 2009-08-31 | N-CSRS | Walgreen Co | WAG | US | Retail-Drug Store | 13,500 | New Holding | 13,500 | 100 % | $522,585 | $526,095 | $3,510 | 0.67 % | $3,510 | | | | | | News Article | History of Fidelity Select Portfolios - Pharmaceuticals Portfolio Ownership Of Walgreen Co |
| 2009-11-02 | 2009-08-31 | N-CSRS | Waters Corp | WAT | US | Instruments-Scientific | 6,100 | Sold Some | -6,900 | -53.07 % | $353,800 | $360,144 | $6,344 | 1.79 % | $-7,176 | | | | | | News Article | History of Fidelity Select Portfolios - Pharmaceuticals Portfolio Ownership Of Waters Corp |
| 2009-11-02 | 2009-08-31 | N-CSRS | Watson Pharmaceuticals Inc | WPI | US | Medical-Generic Drugs | 25,100 | Added More | 25,000 | 25000.00 % | $886,281 | $882,265 | $-4,016 | -0.45 % | $-4,000 | | | | | | News Article | History of Fidelity Select Portfolios - Pharmaceuticals Portfolio Ownership Of Watson Pharmaceuticals Inc |
| 2009-11-02 | 2009-08-31 | N-CSRS | Wellpoint Inc | WLP | US | Medical-Hmo | 1,000 | New Holding | 1,000 | 100 % | $47,610 | $52,140 | $4,530 | 9.51 % | $4,530 | | | | | | News Article | History of Fidelity Select Portfolios - Pharmaceuticals Portfolio Ownership Of Wellpoint Inc |
| 2009-11-02 | 2009-08-31 | N-CSRS | Medivation Inc | MDVN | US | Medical-Biomedical/Gene | 4,303 | No Change | 0 | 0 % | $112,523 | $125,734 | $13,210 | 11.73 % | $0 | | | | | | News Article | History of Fidelity Select Portfolios - Pharmaceuticals Portfolio Ownership Of Medivation Inc |
| 2009-11-02 | 2009-08-31 | N-CSRS | Boston Scientific Corp | BSX | US | Medical Instruments | 9,300 | Sold Some | -5,700 | -38.00 % | $76,353 | $75,237 | $-1,116 | -1.46 % | $684 | | | | | | News Article | History of Fidelity Select Portfolios - Pharmaceuticals Portfolio Ownership Of Boston Scientific Corp |
| 2009-11-02 | 2009-08-31 | N-CSRS | Wyeth | WYE | US | Medical-Drugs | 73,970 | Sold Some | -48,600 | -39.65 % | - | - | - | - % | | | | | | | News Article | History of Fidelity Select Portfolios - Pharmaceuticals Portfolio Ownership Of Wyeth |
| 2009-11-02 | 2009-08-31 | N-CSRS | St Jude Medical Inc | STJ | US | Medical Instruments | 0 | Sold All | -8,000 | -100 % | - | - | - | -0.92 % | $2,560 | | | | | | News Article | History of Fidelity Select Portfolios - Pharmaceuticals Portfolio Ownership Of St Jude Medical Inc |
| 2009-11-02 | 2009-08-31 | N-CSRS | Schering-Plough Corp | SGP | US | Medical-Drugs | 287,090 | Added More | 66,900 | 30.38 % | $8,153,356 | - | - | - % | | | | | | | News Article | History of Fidelity Select Portfolios - Pharmaceuticals Portfolio Ownership Of Schering-Plough Corp |
| 2009-11-02 | 2009-08-31 | N-CSRS | Rite Aid Corp | RAD | US | Retail-Drug Store | 27,000 | Added More | 17,000 | 170.00 % | $34,290 | $34,560 | $270 | 0.78 % | $170 | | | | | | News Article | History of Fidelity Select Portfolios - Pharmaceuticals Portfolio Ownership Of Rite Aid Corp |
| 2009-11-02 | 2009-08-31 | N-CSRS | Basilea Pharmaceutica | PK5.BE | CH | Medical-Biomedical/Gene | 0 | Sold All | -1,170 | -100 % | - | - | - | - % | | | | | | | News Article | History of Fidelity Select Portfolios - Pharmaceuticals Portfolio Ownership Of Basilea Pharmaceutica |
| 2009-11-02 | 2009-08-31 | N-CSRS | Pfizer Inc | PFE | US | Medical-Drugs | 1,519,100 | Added More | 17,100 | 1.13 % | $25,748,745 | $27,890,676 | $2,141,931 | 8.31 % | $24,111 | | | | | | News Article | History of Fidelity Select Portfolios - Pharmaceuticals Portfolio Ownership Of Pfizer Inc |